We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
PRA Group
PRAA
$719M
| $338K | ﹤0.01% |
+17,799
| New | +$316K |
|
|
ENGS
2652
Energys Group
ENGS
$126M
| $336K | ﹤0.01% |
+138,207
| New | +$211K |
|
2653
CALL
Merck
MRK
$366B
| $334K | ﹤0.01% |
+2,600
| New | +$304K |
|
2654
Relay Therapeutics
RLAY
$4.19B
| $334K | ﹤0.01% |
17,843
-923,982
| -98% | -$13.4M |
|
2655
Willdan Group
WLDN
$1.33B
| $333K | ﹤0.01% |
4,215
-22,734
| -84% | -$1.94M |
|
2656
iShares Select U.S. REIT ETF
ICF
$2.01B
| $333K | ﹤0.01% |
+4,920
| New | +$331K |
|
2657
Zillow
ZG
$7.43B
| $333K | ﹤0.01% |
10,600
+1,500
| +16% | +$57.9K |
|
2658
Lakeland Financial Corp
LKFN
$1.49B
| $332K | ﹤0.01% |
5,382
-12,291
| -70% | -$741K |
|
|
CSR
2659
Centerspace
CSR
$885M
| $332K | ﹤0.01% |
+5,907
| New | +$372K |
|
2660
CALL
BlackBerry
BB
$4.61B
| $331K | ﹤0.01% |
+26,200
| New | +$183K |
|
2661
PUT
Wingstop
WING
$2.98B
| $329K | ﹤0.01% |
1,900
-1,900
| -50% | -$299K |
|
2662
GCM Grosvenor
GCMG
$806M
| $329K | ﹤0.01% |
26,752
-379,752
| -93% | -$4.15M |
|
|
AAUC
2663
Allied Gold Corp
AAUC
$3.19B
| $328K | ﹤0.01% |
+13,810
| New | +$390K |
|
2664
iShares MSCI Japan Small-Cap ETF
SCJ
$264M
| $328K | ﹤0.01% |
+3,118
| New | +$322K |
|
|
PBPH
2665
Portfolio Building Block World Pharma and Biotech Index ETF
PBPH
$987M
| $326K | ﹤0.01% |
+12,012
| New | +$306K |
|
2666
Sabre
SABR
$912M
| $324K | ﹤0.01% |
154,907
+5,107
| +3% | +$8.95K |
|
2667
Vera Therapeutics
VERA
$2.54B
| $323K | ﹤0.01% |
+7,531
| New | +$281K |
|
2668
Skillsoft
SKIL
$59.8M
| $322K | ﹤0.01% |
+62,256
| New | +$414K |
|
2669
Companhia Siderúrgica Nacional
SID
$1.64B
| $322K | ﹤0.01% |
350,283
-637,833
| -65% | -$798K |
|
2670
Pure Cycle
PCYO
$267M
| $322K | ﹤0.01% |
30,060
-45,458
| -60% | -$497K |
|
2671
Denison Mines
DNN
$3.03B
| $321K | ﹤0.01% |
104,965
-361,145
| -77% | -$1.26M |
|
2672
iShares MSCI Netherlands ETF
EWN
$662M
| $321K | ﹤0.01% |
+4,565
| New | +$298K |
|
2673
Anika Therapeutics
ANIK
$282M
| $321K | ﹤0.01% |
21,918
-2,013
| -8% | -$29.8K |
|
2674
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.4B
| $320K | ﹤0.01% |
+4,000
| New | +$320K |
|
|
AERO
2675
Grupo Aeromexico SAB de CV
AERO
$2.27B
| $319K | ﹤0.01% |
17,746
-4,347
| -20% | -$69.8K |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.